Read + Share
Amedeo Smart
Independent Medical Education
Breitner J, Meyer PF. Author response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease. Neurology 2020;94:594.PMID: 32229636
Email
LinkedIn
Facebook
Twitter
Privacy Policy